BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Whether immune cells have a prognostic value in the recurrence of papillary thyroid cancer (PTC) needs further investigation.MethodsMultinodular non-toxic goiter (MNG) was taken as normal tissue for the difficulty in obtaining completely normal thyroid tissue (normal thyroid function, no thyroiditis, and no nodules). We compared the composition of mononuclear cells (MNCs) in peripheral blood and thyroid tissues from MNG and PTC patients by high-dimensional flow cytometry profiling and verified the results by multiplex immunohistochemistry. The recurrence rates of PTC patients with different CD8+T cell subset signatures were compared using TCGA dat...
We previously identified the infiltration of CD8+ lymphocytes and COX2 expression as an independent ...
There is an increasing rate of papillary thyroid carcinomas that may never progress to cause symptom...
Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical outcomes ...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
2012-08-22Introduction: Thyroid cancer is the most common endocrine malignancy. Although typically w...
BACKGROUND: As the most common endocrine malignancy in the United States (U.S.), differentiated thyr...
Objectives. The understanding of the mechanisms underlying thyroid cancer immune escape can lead to ...
Objectives. The understanding of the mechanisms underlying thyroid cancer immune escape can lead to ...
BackgroundExploring the immune interface of follicular cell-derived thyroid cancer has prognostic an...
Abstract We have read with great interest the article entitled “Identification of an immune-related ...
We previously identified the infiltration of CD8+ lymphocytes and COX2 expression as an independent ...
There is an increasing rate of papillary thyroid carcinomas that may never progress to cause symptom...
Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical outcomes ...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Wheth...
2012-08-22Introduction: Thyroid cancer is the most common endocrine malignancy. Although typically w...
BACKGROUND: As the most common endocrine malignancy in the United States (U.S.), differentiated thyr...
Objectives. The understanding of the mechanisms underlying thyroid cancer immune escape can lead to ...
Objectives. The understanding of the mechanisms underlying thyroid cancer immune escape can lead to ...
BackgroundExploring the immune interface of follicular cell-derived thyroid cancer has prognostic an...
Abstract We have read with great interest the article entitled “Identification of an immune-related ...
We previously identified the infiltration of CD8+ lymphocytes and COX2 expression as an independent ...
There is an increasing rate of papillary thyroid carcinomas that may never progress to cause symptom...
Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical outcomes ...